Viloki B Patel, NP
Nurse Practitioner · La Jolla
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Scripps Health · 1,450 clinicians in this group
Looking this up.
Hospitals listed: Scripps Memorial Hospital La Jolla. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Viloki B Patel’s office at (858) 455-9100 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Scripps Memorial Hospital La JollaLa Jolla, CAAcute Care Hospital · Physician · Has an emergency department · Birthing-friendlyPart of Scripps Health, which runs 5 hospitalsPatients rate it 4 of 5 · 85% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.38 (1.14 to 1.61), Jul 2022 – Jun 2024Worse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.34 (3.7 to 6.97) · 3,953 cases, Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 18.45 (14.32 to 22.59) · 1,797 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.435, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.292, Oct 2024 – Sep 2025
See every measure and the patient survey for Scripps Memorial Hospital La Jolla
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.38 (1.14 to 1.61) | Worse | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.34 (3.7 to 6.97) · 3,953 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 18.45 (14.32 to 22.59) · 1,797 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.435 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.292 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.52 (0.67 to 2.36) · 2,219 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.42 (149.38 to 221.45) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 118 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 115 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.9 · 334 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 883 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.2 · 701 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 471 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.5 · 6,070 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.51) · 12,149 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.09 to 0.44) · 12,365 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.44 (0.27 to 2.61) · 1,763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.62 (1.37 to 3.87) · 3,530 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.03 (5.11 to 10.96) · 1,777 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.52 (0.1 to 2.94) · 635 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.42 (0 to 0.93) · 8,932 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 192 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.677 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.315 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.418 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.745 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.4 · 665 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 1,187 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 423 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11.7 · 1,058 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -21.5 · 744 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 778 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 195 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 251 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 125 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.7 to 16.5) · 1,158 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.6) · 541 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,573 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 81% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 79% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 60% |
| "YES", patients would definitely recommend the hospital | 85% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$5,298
Medicare paid this office $5,298 for 31 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,612 | $90 |
Who their Medicare patients are
31 Original Medicare patients in 2024. Average age 77 · Under 65 0% · Health risk score 2.15. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Coronary heart disease 74% · Heart failure 74% · Diabetes 52% · Chronic kidney disease 48% · COPD 39%.
The office billed $18,901, Medicare allowed $6,649 and paid $5,298; for 72 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 31 | 72 | 77 | 2.15 | $18,901 | $5,298 |
| 2023 | 35 | 77 | 76 | 2.40 | $21,387 | $5,705 |
| 2022 | 41 | 69 | 77 | 1.78 | $18,854 | $5,046 |
| 2021 | 15 | 19 | 70 | 1.60 | $5,536 | $1,368 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 13 | $1,182 | $91 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,314 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,228 | $51 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $994 | $66 |
Drugs they prescribed that Part D paid
$4,089
Pharmacies billed $4,089 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 20% of their Part D prescriptions (39 of 196) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
178 generic and fewer than 11 brand-name prescriptions · $4,089 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amiodarone | 20 | $437 | $22 |
| Oxycodone | 35 | $182 | $5 |
| Metoprolol | 27 | $147 | $5 |
| Potassium Chloride | 22 | $99 | $5 |
| Furosemide | 26 | $87 | $3 |
Year by year
| 2024 | 196 | 48 | 20% (39) | None | $4,089 |
| 2023 | 222 | 48 | 18% (39) | None | $10,984 |
| 2022 | 275 | 63 | 19% (51) | None | $8,642 |
| 2021 | 69 | 19 | 20% (14) | 16% | $2,238 |
| 2020 | 54 | None | 0% (0) | None | $7,441 |
| 2019 | 93 | 12 | None | None | $8,943 |
| 2018 | 212 | 32 | None | 17% | $6,387 |
| 2017 | 219 | 34 | None | None | $5,931 |
| 2016 | 61 | None | None | None | $2,916 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Amiodarone | 16 | $504 | $32 |
| Oxycodone | 37 | $208 | $6 |
| Potassium Chloride | 27 | $160 | $6 |
| Furosemide | 33 | $138 | $4 |
| Metoprolol | 23 | $134 | $6 |
2022: 5 drugs
| Amiodarone | 21 | $867 | $41 |
| Metoprolol | 40 | $262 | $7 |
| Potassium Chloride | 32 | $232 | $7 |
| Oxycodone | 44 | $221 | $5 |
| Furosemide | 49 | $161 | $3 |
2021: 2 drugs
| Oxycodone | 14 | $69 | $5 |
| Metoprolol | 11 | $68 | $6 |
2019: 1 drug
| Baclofen | 11 | $336 | $31 |
2018: 4 drugs
| Potassium Chloride | 15 | $142 | $9 |
| Atorvastatin | 13 | $107 | $8 |
| Metoprolol | 26 | $97 | $4 |
| Furosemide | 19 | $42 | $2 |
2017: 5 drugs
| Pantoprazole | 15 | $180 | $12 |
| Potassium Chloride | 12 | $136 | $11 |
| Tamsulosin | 11 | $114 | $10 |
| Metoprolol | 14 | $42 | $3 |
| Furosemide | 15 | $33 | $2 |
Money from drug and device companies
$113 in 2025
| 2025 | 5 | 6 | None | $113 |
| 2024 | 4 | 11 | None | $310 |
| 2023 | 5 | 8 | None | $133 |
| 2022 | 1 | 2 | None | $40 |
| 2021 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Getinge USA Sales | Vasoview Hemopro 2 | $35 | 1 payment
|
| Vertex Pharmaceuticals | Journavx | $25 | 1 payment
|
| CVRx | Barostim Neo System | $20 | 2 payments
|
| Medtronic | Avalus | $18 | 1 payment
|
| Abbvie | Linzess | $14 | 1 payment
|
See all 6 published payments
| Getinge USA Sales | Meals · 2025-10-23 | Vasoview Hemopro 2 | $35 |
| Medtronic | Meals · 2025-09-19 | Avalus | $18 |
| Abbvie | Meals · 2025-08-20 | Linzess | $14 |
| CVRx | Meals · 2025-04-30 | Barostim Neo System | $6 |
| Vertex Pharmaceuticals | Meals · 2025-04-07 | Journavx | $25 |
| CVRx | Meals · 2025-03-13 | Barostim Neo System | $15 |
See earlier years (2024, 2023, 2022, 2021)
2024: $310
| Getinge USA Sales | Vasoview Hemopro 2 | $238 | 8 payments
|
| Bolton Medical | Treo Abdominal Stent-Graft System | $33 | 1 payment
|
| Boston Scientific | None | $23 | 1 payment
|
| Medtronic | Penditure | $16 | 1 payment
|
2023: $133
| CVRx | Barostim Neo System | $39 | 3 payments
|
| Getinge USA Sales | Vasoview Hemopro 2 | $34 | 2 payments
|
| Bolton Medical | Relay Thoracic Stent-Graft With Plus Delivery System | $23 | 1 payment
|
| Baxter Healthcare | Floseal | $19 | 1 payment
|
| Medtronic | Ligasure | $19 | 1 payment
|
2022: $40
| Getinge USA Sales | Heartstring III Proximal Seal | $40 | 2 payments
|
2021: $19
| Getinge USA Sales | Oasis | $19 | 1 payment
|
Professional record
- NPI
- 1982052882
- Licence
- CA 95011288, NJ 26NJ00641300
- Group
- Scripps Health
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Nurse practitioner (363L00000X); Federal specialty code 282NC0060X (282NC0060X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2016-06-01
- NPI last updated
- 2019-07-09
This is when the NPI record was last certified, not a medical board exam.